Vaxcyte Inc (NASDAQ: PCVX) is 34.87% higher on its value in year-to-date trading and has touched a low of $53.83 and a high of $121.06 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PCVX stock was last observed hovering at around $87.08 in the last trading session, with the day’s loss setting it -1.17%.
Currently trading at $85.91, the stock is -4.38% and -12.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.22 million and changing -1.34% at the moment leaves the stock 1.23% off its SMA200. PCVX registered 38.74% gain for a year compared to 6-month gain of 12.86%. The firm has a 50-day simple moving average (SMA 50) of $98.565 and a 200-day simple moving average (SMA200) of $84.7959.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -4.34% loss in the last 1 month and extending the period to 3 months gives it a -25.35%, and is -5.74% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.76% over the week and 3.64% over the month.
Vaxcyte Inc (PCVX) has around 254 employees, a market worth around $10.56B and $0.00M in sales. Distance from 52-week low is 59.60% and -29.03% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.77%).
The EPS is expected to grow by 5.63% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Vaxcyte Inc (PCVX) Top Institutional Holders
460.0 institutions hold shares in Vaxcyte Inc (PCVX), with institutional investors hold 112.51% of the company’s shares. The shares outstanding are 124.43M, and float is at 120.31M with Short Float at 9.17%. Institutions hold 111.95% of the Float.
The top institutional shareholder in the company is FMR LLC with over 16.17 million shares valued at $1.22 billion. The investor’s holdings represent 13.788% of the PCVX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 9.94 million shares valued at $750.56 million to account for 8.477 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 9.8 million shares representing 8.3552% and valued at over $739.77 million, while JANUS HENDERSON GROUP PLC holds 7.5637 of the shares totaling 8.87 million with a market value of $669.72 million.
Vaxcyte Inc (PCVX) Insider Activity
The most recent transaction is an insider sale by GUGGENHIME ANDREW, the company’s PRESIDENT AND CFO. SEC filings show that GUGGENHIME ANDREW sold 8,000 shares of the company’s common stock on Dec 18 ’24 at a price of $88.78 per share for a total of $0.71 million. Following the sale, the insider now owns 0.11 million shares.
Still, SEC filings show that on Dec 09 ’24, PICKERING GRANT (CHIEF EXECUTIVE OFFICER) disposed off 2,366 shares at an average price of $92.25 for $0.22 million. The insider now directly holds 136,215 shares of Vaxcyte Inc (PCVX).
